JET-GBS - Japanese Eculizumab Trial for GBS

NCT02493725 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

34

Enrollment

OTHER

Sponsor class

Conditions

Gullain Barre Syndrome

Interventions

DRUG: Eculizumab
DRUG: Placebo

Sponsor

Chiba University

Collaborators

[object Object]